David Pogue, a tech writer for the New York Times, reports on a new invention called the SimpleShot. The device provides an injection of glucagon, a hormone produced by the pancreas that stimulates an increase in blood sugar levels. Diabetics on insulin are often at risk for hypoglycemia, an abnormally low level of glucose in the blood. Normally administering the glucagon involves mixing a powder and a solution. The invention was a finalist in the Modern Marvels Invent NOW Challenge.

You Might Also Like

  • Rich
    31st August 2007 at 2:20 PM

    Just a couple of thoughts. A company in Germany named Vetter holds a patent on a dual chamber cartridge designed for a powder and diluent to be mixed prior to use. They also hold a patent on a dual chamber syringe. In addition there is another patent filed that describes the use of a dual chamber device and injector specifically for glucagon and a liquid for emergency hypoglycemia.

    It appears that Modern Marvels didn't do any research on existing patents, products or devices under development.

  • Bernard Farrell
    20th May 2007 at 2:12 PM

    FINALLY, something new in the glucagon field.

    The current glucagon kits look like they were designed in the 1950s. And this whole idea of mixing up powder properly while someone you love (generally) is having some severe reaction is just unbelievable.

    Thanks for the pointer Khurt

%d bloggers like this: